European Medicines Agency starts rolling review of Evusheld (tixagevimab and cilgavimab) for prevention of Covid-19 in adults, EMA

Tixagevimab and cilgavimab are monoclonal antibodies that attach to the spike protein of SARS-CoV-2 and stop the virus from entering the body ' s cells and causing infection. The decision to start the rolling review was based on preliminary results from clinical studies.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news